Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2017 (2017), Article ID 6034692, 12 pages
https://doi.org/10.1155/2017/6034692
Research Article

Troxerutin Reduces Kidney Damage against BDE-47-Induced Apoptosis via Inhibiting NOX2 Activity and Increasing Nrf2 Activity

1School of Environment Science and Spatial Informatics, China University of Mining and Technology, Xuzhou, Jiangsu Province 221008, China
2Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, 101 Shanghai Road, Xuzhou, Jiangsu Province 221116, China

Correspondence should be addressed to Yuanlin Zheng

Received 17 April 2017; Accepted 18 June 2017; Published 15 October 2017

Academic Editor: Haobo Li

Copyright © 2017 Qun Shan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. M. Sanders, L. J. Chen, E. H. Lebetkin, and L. T. Burka, “Metabolism and disposition of 2,2,4,4-tetrabromodiphenyl ether following administration of single or multiple doses to rats and mice,” Xenobiotica, vol. 36, pp. 103–117, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. D. F. Staskal, J. J. Diliberto, and L. S. Birnbaum, “Disposition of BDE 47 in developing mice,” Toxicological Sciences, vol. 90, pp. 309–316, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Emond, J. H. Raymer, W. B. Studabaker, C. E. Garner, and L. S. Birnbaum, “A physiologically based pharmacokinetic model for developmental exposure to BDE-47 in rats,” Toxicology and Applied Pharmacology, vol. 242, pp. 290–298, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Hakk, J. K. Huwe, K. Murphy, and D. Rutherford, “Metabolism of 2,2,4,4-tetrabromodiphenyl ether (BDE-47) in chickens,” Journal of Agricultural and Food Chemistry, vol. 58, pp. 8757–8762, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Eriksson, E. Jakobsson, and A. Fredriksson, “Brominated flame retardants: a novel class of developmental neurotoxicants in our environment?” Environmental Health Perspectives, vol. 109, pp. 903–908, 2001. View at Google Scholar
  6. M. M. Dingemans, G. M. Ramakers, F. Gardoni et al., “Neonatal exposure to brominated flame retardant BDE-47 reduces long-term potentiation and postsynaptic protein levels in mouse hippocampus,” Environmental Health Perspectives, vol. 115, pp. 865–870, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. L. G. Costa and G. Giordano, “Developmental neurotoxicity of polybrominated diphenyl ether (PBDE) flame retardants,” Neurotoxicology, vol. 28, pp. 1047–1067, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. P. He, W. He, A. Wang et al., “PBDE-47-induced oxidative stress, DNA damage and apoptosis in primary cultured rat hippocampal neurons,” Neurotoxicology, vol. 29, pp. 124–129, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. P. He, A. G. Wang, T. Xia et al., “Mechanism of the neurotoxic effect of PBDE-47 and interaction of PBDE-47 and PCB153 in enhancing toxicity in SH-SY5Y cells,” Neurotoxicology, vol. 30, pp. 10–15, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. W. He, P. He, A. Wang, T. Xia, B. Xu, and X. Chen, “Effects of PBDE-47 on cytotoxicity and genotoxicity in human neuroblastoma cells in vitro,” Mutation Research, vol. 649, pp. 62–70, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. V. M. Richardson, D. F. Staskal, D. G. Ross, J. J. Diliberto, M. J. DeVito, and L. S. Birnbaum, “Possible mechanisms of thyroid hormone disruption in mice by BDE 47, a major polybrominated diphenyl ether congener,” Toxicology and Applied Pharmacology, vol. 226, pp. 244–250, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Wu, L. Cao, F. Li, P. Lian, and J. Zhao, “Multiple biomarkers of the cytotoxicity induced by BDE-47 in human embryonic kidney cells,” Chemosphere, vol. 126, pp. 32–39, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. H. R. Park and R. Loch-Caruso, “Protective effect of (±)α-tocopherol on brominated diphenyl ether-47-stimulated prostaglandin pathways in human extravillous trophoblasts in vitro,” Toxicology In Vitro, vol. 29, pp. 1309–1318, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Yeh, S. E. Kruse, D. J. Marcinek, and E. P. Gallagher, “Effect of omega-3 fatty acid oxidation products on the cellular and mitochondrial toxicity of BDE 47,” Toxicology In Vitro, vol. 29, pp. 672–680, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. Z. F. Zhang, Y. Q. Zhang, S. H. Fan et al., “Troxerutin protects against 2,2,4,4-tetrabromodiphenyl ether (BDE-47)-induced liver inflammation by attenuating oxidative stress-mediated NAD+-depletion,” Journal of Hazardous Materials, vol. 283, pp. 98–109, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. Z. F. Zhang, Q. Shan, J. Zhuang et al., “Troxerutin inhibits 2,2,4,4-tetrabromodiphenyl ether (BDE-47)-induced hepatocyte apoptosis by restoring proteasome function,” Toxicology Letters, vol. 233, pp. 246–257, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. N. A. Bergstein, “Clinical study on the efficacy of O-(β-hydroxyethyl) rutoside (HR) in varicosis of pregnancy,” The Journal of International Medical Research, vol. 3, pp. 189–193, 1975. View at Publisher · View at Google Scholar
  18. K. Sumboonnanonda and P. Lertsithichai, “Clinical study of the Ginko biloba--Troxerutin-Heptaminol Hce in the treatment of acute hemorrhoidal attacks,” Journal of the Medical Association of Thailand, vol. 87, pp. 137–142, 2004. View at Google Scholar
  19. W. Vanscheidt, E. Rabe, B. Naser-Hijazi et al., “The efficacy and safety of a coumarin-/troxerutin-combination (SB-LOT) in patients with chronic venous insufficiency: a double blind placebo-controlled randomised study,” Vasa, vol. 31, pp. 185–190, 2002. View at Publisher · View at Google Scholar
  20. S. Babri, G. Mohaddes, I. Feizi et al., “Effect of troxerutin on synaptic plasticity of hippocampal dentate gyrus neurons in a β-amyloid model of Alzheimer’s disease: an electrophysiological study,” European Journal of Pharmacology, vol. 732, pp. 19–25, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Sampath and B. Karundevi, “Effect of troxerutin on insulin signaling molecules in the gastrocnemius muscle of high fat and sucrose-induced type-2 diabetic adult male rat,” Molecular and Cellular Biochemistry, vol. 395, pp. 11–27, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. Z. F. Zhang, S. H. Fan, Y. L. Zheng et al., “Troxerutin protects the mouse liver against oxidative stress-mediated injury induced by D-galactose,” Journal of Agricultural and Food Chemistry, vol. 57, pp. 7731–7736, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Lu, D. M. Wu, B. Hu et al., “Chronic administration of troxerutin protects mouse brain against D-galactose-induced impairment of cholinergic system,” Neurobiology of Learning and Memory, vol. 93, pp. 157–164, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. S. H. Fan, Z. F. Zhang, Y. L. Zheng et al., “Troxerutin protects the mouse kidney from d-galactose-caused injury through anti-inflammation and anti-oxidation,” International Immunopharmacology, vol. 9, pp. 91–96, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Lu, D. M. Wu, Z. H. Zheng, Y. L. Zheng, B. Hu, and Z. F. Zhang, “Troxerutin protects against high cholesterol-induced cognitive deficits in mice,” Brain, vol. 134, pp. 783–797, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Lu, D. M. Wu, Y. L. Zheng et al., “Troxerutin counteracts domoic acid-induced memory deficits in mice by inhibiting CCAAT/enhancer binding protein β-mediated inflammatory response and oxidative stress,” Journal of Immunology, vol. 190, pp. 3466–7349, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. Z. F. Zhang, S. H. Fan, Y. L. Zheng et al., “Troxerutin improves hepatic lipid homeostasis by restoring NAD+-depletion-mediated dysfunction of lipin 1 signaling in high-fat diet-treated mice,” Biochemical Pharmacology, vol. 91, pp. 74–86, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. J. L. Lim, M. M. Wilhelmus, H. E. de Vries, B. Drukarch, J. J. Hoozemans, and J. van Horssen, “Antioxidative defense mechanisms controlled by Nrf2: state-of-the-art and clinical perspectives in neurodegenerative diseases,” Archives of Toxicology, vol. 88, pp. 1773–1786, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. K. Asaba, A. Tojo, M. L. Onozato et al., “Effects of NADPH oxidase inhibitor in diabetic nephropathy,” Kidney International, vol. 67, pp. 1890–1898, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. F. Tao, M. Abou-Elwafa Abdallah, D. C. Ashworth, P. Douglas, M. B. Toledano, and S. Harrad, “Emerging and legacy flame retardants in UK human milk and food suggest slow response to restrictions on use of PBDEs and HBCDD,” Environment International, vol. 105, pp. 95–104, 2017. View at Publisher · View at Google Scholar
  31. H. Bjermo, M. Aune, T. Cantillana et al., “Serum levels of brominated flame retardants (BFRs: PBDE, HBCD) and influence of dietary factors in a population-based study on Swedish adults,” Chemosphere, vol. 167, pp. 485–491, 2017. View at Publisher · View at Google Scholar
  32. S. A. Marchitti, S. E. Fenton, P. Mendola, J. F. Kenneke, and E. P. Hines, “Polybrominated diphenyl ethers in human milk and serum from the U.S. EPA MAMA study: modeled predictions of infant exposure and considerations for risk assessment,” Environmental Health Perspectives, vol. 125, pp. 706–713, 2017. View at Publisher · View at Google Scholar
  33. M. H. Müller, A. Polder, O. B. Brynildsrud et al., “Brominated flame retardants (BFRs) in breast milk and associated health risks to nursing infants in Northern Tanzania,” Environment International, vol. 89-90, pp. 38–47, 2016. View at Publisher · View at Google Scholar · View at Scopus
  34. Z. J. Chen, H. Y. Liu, K. L. Ho et al., “Hydroxylated polybrominated diphenyl ethers (OH-PBDEs) in paired maternal and neonatal samples from South China: placental transfer and potential risks,” Environmental Research, vol. 148, pp. 72–78, 2016. View at Publisher · View at Google Scholar · View at Scopus
  35. S. A. Marchitti, C. S. Mazur, C. M. Dillingham et al., “Inhibition of the human ABC efflux transporters P-gp and BCRP by the BDE-47 hydroxylated metabolite 6-OH-BDE-47: considerations for human exposure,” Toxicological Sciences, vol. 155, pp. 270–282, 2017. View at Publisher · View at Google Scholar
  36. Q. Saquib, M. A. Siddiqui, J. Ahmed et al., “Hazards of low dose flame-retardants (BDE-47 and BDE-32): influence on transcriptome regulation and cell death in human liver cells,” Journal of Hazardous Materials, vol. 308, pp. 37–49, 2016. View at Publisher · View at Google Scholar · View at Scopus
  37. C. Jiang, S. Zhang, H. Liu et al., “The role of the IRE1 pathway in PBDE-47-induced toxicity in human neuroblastoma SH-SY5Y cells in vitro,” Toxicology Letters, vol. 211, pp. 325–333, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. C. Yan, D. Huang, and Y. Zhang, “The involvement of ROS overproduction and mitochondrial dysfunction in PBDE-47-induced apoptosis on Jurkat cells,” Experimental and Toxicologic Pathology, vol. 63, pp. 413–417, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. Z. Zhang, S. Li, L. Liu et al., “Environmental exposure to BDE47 is associated with increased diabetes prevalence: evidence from community-based case-control studies and an animal experiment,” Scientific Reports, vol. 6, article 27854, 2016. View at Publisher · View at Google Scholar · View at Scopus
  40. Z. Zhang, Y. Yu, H. Xu et al., “High-fat diet aggravates 2,2,4,4-tetrabromodiphenyl ether-inhibited testosterone production via DAX-1 in Leydig cells in rats,” Toxicology and Applied Pharmacology, vol. 323, pp. 1–8, 2017. View at Publisher · View at Google Scholar
  41. L. M. Fan, S. Cahill-Smith, L. Geng, J. Du, G. Brooks, and J. M. Li, “Aging-associated metabolic disorder induces Nox2 activation and oxidative damage of endothelial function,” Free Radical Biology & Medicine, vol. 108, pp. 940–951, 2017. View at Publisher · View at Google Scholar
  42. J. Lu, D. M. Wu, Y. L. Zheng, B. Hu, W. Cheng, and Z. F. Zhang, “Purple sweet potato color attenuates domoic acid-induced cognitive deficits by promoting estrogen receptor-α-mediated mitochondrial biogenesis signaling in mice,” Free Radical Biology & Medicine, vol. 52, pp. 646–659, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. M. A. Aminzadeh, S. B. Nicholas, K. C. Norris, and N. D. Vaziri, “Role of impaired Nrf2 activation in the pathogenesis of oxidative stress and inflammation in chronic tubulo-interstitial nephropathy,” Nephrology, Dialysis, Transplantation, vol. 28, pp. 2038–2045, 2013. View at Publisher · View at Google Scholar · View at Scopus
  44. A. S. Arellano-Buendía, M. Tostado-González, F. E. García-Arroyo et al., “Anti-inflammatory therapy modulates Nrf2-Keap1 in kidney from rats with diabetes,” Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 4693801, 11 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  45. L. Kong, Y. Wang, M. Luo, Y. Tan, W. Cui, and L. Miao, “Prevention of streptozotocin-induced diabetic nephropathy by MG132: possible roles of Nrf2 and IκB,” Oxidative Medicine and Cellular Longevity, vol. 2017, Article ID 3671751, 12 pages, 2017. View at Publisher · View at Google Scholar
  46. H. R. Park and R. Loch-Caruso, “Protective effect of nuclear factor E2-related factor 2 on inflammatory cytokine response to brominated diphenyl ether-47 in the HTR-8/SVneo human first trimester extravillous trophoblast cell line,” Toxicology and Applied Pharmacology, vol. 281, pp. 67–77, 2014. View at Publisher · View at Google Scholar · View at Scopus
  47. W. Sun, X. Liu, H. Zhang et al., “Epigallocatechin gallate upregulates NRF2 to prevent diabetic nephropathy via disabling KEAP1,” Free Radical Biology & Medicine, vol. 108, pp. 840–857, 2017. View at Publisher · View at Google Scholar
  48. H. K. Bayele, E. S. Debnam, and K. S. Srai, “Nrf2 transcriptional derepression from Keap1 by dietary polyphenols,” Biochemical and Biophysical Research Communications, vol. 469, pp. 521–528, 2016. View at Publisher · View at Google Scholar · View at Scopus
  49. S. Elmore, “Apoptosis: a review of programmed cell death,” Toxicologic Pathology, vol. 35, pp. 495–516, 2007. View at Publisher · View at Google Scholar · View at Scopus
  50. B. D. Sahu, S. Tatireddy, M. Koneru et al., “Naringin ameliorates gentamicin-induced nephrotoxicity and associated mitochondrial dysfunction, apoptosis and inflammation in rats: possible mechanism of nephroprotection,” Toxicology and Applied Pharmacology, vol. 277, pp. 8–20, 2014. View at Publisher · View at Google Scholar · View at Scopus
  51. I. Burlaka, L. M. Nilsson, L. Scott et al., “Prevention of apoptosis averts glomerular tubular disconnection and podocyte loss in proteinuric kidney disease,” Kidney International, vol. 90, pp. 135–148, 2016. View at Publisher · View at Google Scholar · View at Scopus
  52. L. G. Costa, C. Pellacani, K. Dao, T. J. Kavanagh, and P. J. Roque, “The brominated flame retardant BDE-47 causes oxidative stress and apoptotic cell death in vitro and in vivo in mice,” Neurotoxicology, vol. 48, pp. 68–76, 2015. View at Publisher · View at Google Scholar · View at Scopus
  53. Q. Y. Lv, B. Wan, L. H. Guo, L. Zhao, and Y. Yang, “In vitro immune toxicity of polybrominated diphenyl ethers on murine peritoneal macrophages: apoptosis and immune cell dysfunction,” Chemosphere, vol. 120, pp. 621–630, 2015. View at Publisher · View at Google Scholar · View at Scopus
  54. C. M. Liu, J. Q. Ma, and Y. Lou, “Chronic administration of troxerutin protects mouse kidney against D-galactose-induced oxidative DNA damage,” Food and Chemical Toxicology, vol. 48, pp. 2809–2817, 2010. View at Publisher · View at Google Scholar · View at Scopus